RCM
JAZZ icon

Reynolds Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Reynolds Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,200
Closed -$309K – 134
2015
Q4 		$309K Sell
2,200
-800
-27% -$111K 0.34% 94
2015
Q3 		$398K Sell
3,000
-200
-6% -$34.4K 0.5% 68
2015
Q2 		$563K Sell
3,200
-300
-9% -$53.9K 0.55% 48
2015
Q1 		$605K Buy
3,500
+700
+25% +$120K 0.53% 47
2014
Q4 		$458K Buy
2,800
+1,100
+65% +$183K 0.38% 86
2014
Q3 		$273K Sell
1,700
-1,900
-53% -$292K 0.26% 144
2014
Q2 		$529K Sell
3,600
-1,000
-22% -$139K 0.36% 76
2014
Q1 		$638K Sell
4,600
-500
-10% -$75.3K 0.41% 59
2013
Q4 		$645K Buy
5,100
+600
+13% +$62.1K 0.36% 58
2013
Q3 		$414K Sell
4,500
-300
-6% -$24.2K 0.27% 114
2013
Q2 		$330K Buy
+4,800
New +$293K 0.24% 160

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Reynolds Capital Management's JAZZ Position: Q1 2016 in Review

Reynolds Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2016, closing a stake of 2,200 shares — an estimated $309K sold.

Reynolds Capital Management first reported a position in JAZZ in Q2 2013 and held it in 11 quarters. The position peaked at $645K in Q4 2013. 340 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

  • Reynolds Capital Management reported no remaining Jazz Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Reynolds Capital Management sold 2,200 Jazz Pharmaceuticals shares in Q1 2016, an estimated $309K.
  • Reynolds Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Reynolds Capital Management's Jazz Pharmaceuticals position peaked at $645K in Q4 2013.
  • 340 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.